Novo Nordisk partnered with Boston startup Vivtex to develop next‑generation oral obesity and diabetes pills. The deal could deliver up to $2.1 billion to the local biotech.

Massachusetts plans to join the GUARDIAN newborn genome‑screening pilot that tests for 450+ treatable genetic conditions. The voluntary program would require state review before enrollment begins.

Klaviyo co-founders Ed Hallen and Andrew Bialecki pledged $6 million to MIT’s delta v accelerator, boosting per-team funding and mentorship to help keep startups in Boston.

Generate Biomedicines filed to raise up to $425M in a Nasdaq IPO as it advances an AI‑designed antibody into Phase 3 and leans on partnerships with Amgen and Novartis.

Beth Israel has started offering Clairity Breast, an FDA‑authorized AI that predicts five‑year breast cancer risk from routine mammograms. The tool is available now at BIDMC’s BreastCare Center.

Charles River named Glenn Coleman as CFO and Kerry Dailey as chief legal officer as it reshuffles leadership amid revenue softness and activist pressure.

BIDMC doctors report deep remissions for some myeloma patients after CAR T therapy, while local manufacturing and vaccine research aim to broaden access.

Governor Maura Healey announced a ChatGPT-powered assistant for state employees, promising training and privacy safeguards as the tool is phased into agencies.

Boston Dynamics demonstrates its new Atlas robot, designed for industrial automation, at CES, with notable features such as a 50 kg lifting capacity and the ability to swap its own batteries.

MIT researchers discovered persistent microcompartments in the genome during cell division, challenging the belief that the genome's 3D structure disassembles completely during this process.

Kimaya Lecamwasam, a doctoral candidate at MIT, merges neuroscience and music to create mental health interventions, coining "pharmamusicology" and researching music's impact on well-being.

MIT engineers have developed a method to detach cells from surfaces using electrochemically generated bubbles, potentially increasing efficiency in biotech and other industries.

MIT postdoc Giorgio Rizzo is developing sustainable fertilizers aimed at reducing environmental impact and enhancing plant resistance, and has received a Kavanaugh Fellowship to further his work.